Literature DB >> 29679265

Focus Groups and In-depth Interviews to Guide the Development of Lung Cancer Screening Informational Materials.

Anushree Sharma1, Richard O'Connor2, Paula Celestino2, Samantha Killion2, Laurie Griswold-Krupski3, Maansi Bansal-Travers4.   

Abstract

Lung cancer is one of the most lethal cancers in the USA. In 2013, new guidelines issued by the United States Preventive Services Task Force recommended lung cancer screening using low-dose computed tomography among a selected group of high-risk individuals. Specifically, lung cancer screening is recommended for heavy smokers between the ages of 55 to 79, with at least 30 pack-year smoking exposure. Former smokers who meet these guidelines and stopped smoking ≤ 15 years ago are also eligible. There is a need to promote lung cancer screening to increase early diagnosis rates and treatment options, thereby decreasing disease-specific mortality. This study was conducted to refine educational materials used to inform eligible high-risk individuals about the risks and benefits of lung cancer screening. Focus groups (n = 16) and in-depth telephone interviews (n = 5) were conducted among screening-eligible participants recruited from western New York. Main themes that emerged from the discussions included cost of obtaining the exam, eligibility criteria/information about the exam, apprehension regarding results, and an increased desire for discussions with their physician to learn more about the screening. The information gained from this study is vital to understanding concerns held by current and former smokers regarding lung cancer screening, as well as critical to determining which information is most valuable for decreasing barriers and correcting misperceptions about the lung cancer screening exam.

Entities:  

Keywords:  Lung cancer; Prevention; Screening; Smoking; Tobacco

Year:  2019        PMID: 29679265     DOI: 10.1007/s13187-018-1362-4

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  13 in total

1.  Who uses the Smoker's Quitline in Massachusetts?

Authors:  Marianne N Prout; O Martinez; J Ballas; A C Geller; T L Lash; D Brooks; T Heeren
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

2.  Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women.

Authors:  Elizabeth Selvin; Kate M Brett
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

3.  Evidence-Based Clinical Prevention in the Era of the Patient Protection and Affordable Care Act: The Role of the US Preventive Services Task Force.

Authors:  Albert L Siu; Kirsten Bibbins-Domingo; David Grossman
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

4.  Medicare Approves Coverage for Lung Cancer Screening: The Case for Symptomatic Screening.

Authors:  Vivek Verma; Sushil Beriwal
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

5.  Who calls QUIT? The characteristics of smokers seeking advice via a telephone helpline compared with smokers attending a clinic and those in the general population.

Authors:  H Gilbert; S Sutton; G Sutherland
Journal:  Public Health       Date:  2005-10       Impact factor: 2.427

6.  Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians.

Authors:  Jennifer L Ersek; Jan M Eberth; Karen Kane McDonnell; Scott M Strayer; Erica Sercy; Kathleen B Cartmell; Daniela B Friedman
Journal:  Cancer       Date:  2016-06-13       Impact factor: 6.860

7.  Patient willingness and barriers to receiving a CT scan for lung cancer screening.

Authors:  Jennifer Delmerico; Andrew Hyland; Paula Celestino; Mary Reid; K Michael Cummings
Journal:  Lung Cancer       Date:  2014-03-13       Impact factor: 5.705

8.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

9.  Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening.

Authors:  Margaret M Byrne; Joel Weissfeld; Mark S Roberts
Journal:  Med Decis Making       Date:  2008-08-25       Impact factor: 2.583

10.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

View more
  4 in total

1.  Correction to: Development of Decisional Values Statements for Lung Cancer Screening among African American Smokers.

Authors:  Randi M Williams; Kenneth H Beck; James Butler; Sunmin Lee; Min Qi Wang; Kathryn L Taylor; Cheryl L Knott
Journal:  J Cancer Educ       Date:  2020-04       Impact factor: 2.037

2.  Development of Decisional Values Statements for Lung Cancer Screening Among African American Smokers.

Authors:  Randi M Williams; Kenneth H Beck; James Butler; Sunmin Lee; Min Qi Wang; Kathryn L Taylor; Cheryl L Knott
Journal:  J Cancer Educ       Date:  2020-04       Impact factor: 2.037

3.  Barriers, Facilitators, and Suggested Interventions for Lung Cancer Screening Among a Rural Screening-Eligible Population.

Authors:  Jenna E Schiffelbein; Kathleen L Carluzzo; Rian M Hasson; Jennifer A Alford-Teaster; Inger Imset; Tracy Onega
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

4.  MicroRNA-133a inhibits the proliferation of non-small cell lung cancer by targeting YES1.

Authors:  Yuyao Shen; Fangwei Chen; Yanchao Liang
Journal:  Oncol Lett       Date:  2019-11-01       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.